SMG
Scotts Miracle-Gro Co
NYSE · Chemicals
$66.34
+1.30 (+2.00%)
Income Statement
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Revenue | 3.37B | 3.54B | 2.35B | 2.16B | 2.15B |
| Net Income | 143.57M | 135.36M | 191.42M | 158.81M | 149.46M |
| EPS | — | — | — | — | — |
| Profit Margin | 4.3% | 4.0% | 8.2% | 7.4% | 6.9% |
| Rev Growth | -4.5% | -4.5% | +2.9% | +14.3% | +17.5% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Total Debt | 1.83B | 1.83B | 1.34B | 1.31B | 1.24B |
| Total Equity | 91.19M | 91.19M | 2.03B | 1.85B | 1.78B |
| D/E Ratio | 20.11 | 20.11 | 0.66 | 0.71 | 0.70 |
Cash Flow
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| EBITDA | 367.82M | 366.04M | 275.16M | 251.72M | 263.49M |
| Free Cash Flow | — | — | 187.64M | 163.95M | 114.67M |